Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research, Chandigarh, 160012, India.
School of Health and Wellbeing, College of Medical, Veterinary and Life Sciences, Health Economics and Health Technology Assessment, University of Glasgow, Glasgow, UK.
Appl Health Econ Health Policy. 2023 Jan;21(1):131-140. doi: 10.1007/s40258-022-00763-8. Epub 2022 Sep 22.
A comprehensive package of immunization services is an internal component of the Essential Health Service Package (ESP) implemented by Government of Lao People's Democratic Republic (Lao PDR). Thus, the cost of delivering the immunization program and its feasibility given the fiscal space emerges as an important policy question. The present analysis was undertaken to estimate the total cost of implementing the immunization program under ESP, determinants of total cost and the program's fiscal implications from the government's perspective.
We employed a normative costing approach for costing of immunization services under ESP. Standard treatment guidelines (STGs) from both within and outside Lao PDR were considered to identify the resource use for each vaccine delivery. Subsequently, cost per dose administered and fully immunized beneficiary were computed. We assessed the fiscal space for financing immunization services in Lao PDR by adapting the decomposition method given by Tandon et al. RESULTS: In 2019, the estimated total cost of financing immunization in Lao PDR was US$12 million, which will increase in 2025 by 1.75 times, to US$21 million. The per capita budget for immunization needs to increase from about US$2 to US$7. Introduction of newer vaccines in the immunization schedule accounts for the major share (60%) of the increased cost for financing immunization. In view of current fiscal space, the government immunization expenditure (GIE) allocations will be adequate only in a scenario where no new vaccine is introduced under ESP in future years.
The current fiscal space would fall short of meeting the aspirational goals of ESP-Immunization for the introduction of newer vaccines in Lao PDR. The present analysis of the fiscal space provides important evidence to support a greater role for the Global Alliance for Vaccine Initiative (GAVI) to continue to finance immunization in Lao PDR. A publicly financed immunization model in Lao PDR would require significant strategic amendments with low short-term viability.
全面的免疫服务套餐是老挝人民民主共和国(老挝)政府实施的基本卫生服务套餐(ESP)的内部组成部分。因此,提供免疫规划的成本及其在财政空间内的可行性成为一个重要的政策问题。本分析旨在估算 ESP 下免疫规划的总成本、总成本的决定因素以及从政府角度出发该规划的财政影响。
我们采用规范成本法估算 ESP 下的免疫服务成本。我们考虑了来自老挝国内外的标准治疗指南(STG),以确定每种疫苗接种的资源利用情况。随后,计算了每剂次接种和完全免疫受益人的成本。我们通过采用 Tandon 等人提出的分解方法来评估老挝为免疫服务供资的财政空间。
2019 年,老挝免疫融资的估计总成本为 1200 万美元,到 2025 年将增加 1.75 倍,达到 2100 万美元。人均免疫预算需要从 2 美元左右增加到 7 美元。免疫规划时间表中引入新疫苗占融资免疫增加成本的主要份额(60%)。鉴于当前的财政空间,如果未来几年 ESP 下不引入新疫苗,政府免疫支出(GIE)分配将仅足够。
目前的财政空间不足以实现老挝 ESP-免疫引入新疫苗的理想目标。对财政空间的本分析为全球疫苗免疫联盟(GAVI)发挥更大作用继续为老挝提供免疫提供了重要证据。老挝的公共融资免疫模式需要进行重大战略修订,短期可行性低。